檢索結果 - Lisa Pieri

Refine Results
  1. 1
    <i>JAK2</i> allele burden in the myeloproliferative neoplasms: effects on phenotype, prognosis and change with treatment

    <i>JAK2</i> allele burden in the myeloproliferative neoplasms: effects on phenotype, prognosis and change with treatment 由 Alessandro M. Vannucchi, Lisa Pieri, Paola Guglielmelli

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Ruxolitinib‐induced reversal of alopecia universalis in a patient with essential thrombocythemia

    Ruxolitinib‐induced reversal of alopecia universalis in a patient with essential thrombocythemia 由 Lisa Pieri, Paola Guglielmelli, Alessandro M. Vannucchi

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera

    The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera 由 Lisa Pieri, Costanza Bogani, Paola Guglielmelli, Maria Zingariello, R. A. Rana, Niccolò Bartalucci, Alberto Bosi, Alessandro M. Vannucchi

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

    Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia 由 Giada Rotunno, Carmela Mannarelli, Paola Guglielmelli, Annalisa Pacilli, Alessandro Pancrazzi, Lisa Pieri, Tiziana Fanelli, Alberto Bosi, Alessandro M. Vannucchi

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib

    JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib 由 Lisa Pieri, Alessandro Pancrazzi, Annalisa Pacilli, Claudia Rabuzzi, Giada Rotunno, Tiziana Fanelli, Paola Guglielmelli, Rajmonda Fjerza, Chiara Paoli, Srđan Verstovšek, Alessandro M. Vannucchi

    出版 2015
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  6. 6
    Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia

    Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia 由 Elisabetta Antonioli, Paola Guglielmelli, G Poli, Costanza Bogani, Alessandro Pancrazzi, Giovanni Longo, Vanessa Ponziani, Lorenzo Tozzi, Lisa Pieri, Valeria Santini, Alberto Bosi, Alessandro M. Vannucchi

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value

    Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value 由 A.M. Vannucchi, Giada Rotunno, Niccolò Bartalucci, G Raugei, Valentina Carrai, Manjola Balliu, Anna Gallì, Annalisa Pacilli, Laura Calabresi, Rajmonda Fjerza, Lisa Pieri, Alberto Bosi, Rossella Manfredini, Paola Guglielmelli

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms

    Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms 由 Alessandro M. Vannucchi, Giovanna Masala, Elisabetta Antonioli, Maria Chiara Susini, Paola Guglielmelli, Lisa Pieri, Laura Maggi, Saverio Caini, Domenico Palli, Costanza Bogani, Vanessa Ponziani, Alessandro Pancrazzi, Francesco Annunziato, Alberto Bosi

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results

    Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results 由 Srđan Verstovšek, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Elisa Rumi, Elisabetta Gattoni, Lisa Pieri, Hui‐Ling Zhen, Muriel Granier, Albert Assad, Mario Cazzola, Hagop M. Kantarjian, Tiziano Barbui, Alessandro M. Vannucchi

    出版 2017
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  10. 10
    The effect of arterial hypertension on thrombosis in low‐risk polycythemia vera

    The effect of arterial hypertension on thrombosis in low‐risk polycythemia vera 由 Tiziano Barbui, Alessandro M. Vannucchi, Alessandra Carobbio, Elisa Rumi, Guido Finazzi, Heinz Gisslinger, Marco Ruggeri, Maria Luigia Randi, Mario Cazzola, Alessandro Rambaldi, Bettina Gisslinger, Lisa Pieri, Jüergen Thiele, Animesh Pardanani, Ayalew Tefferi

    出版 2016
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  11. 11
    Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele

    Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele 由 Paola Guglielmelli, Giovanni Barosi, Giorgina Specchia, Alessandro Rambaldi, Francesco Lo‐Coco, Elisabetta Antonioli, Lisa Pieri, Alessandro Pancrazzi, Vanessa Ponziani, Federica Delaini, Giovanni Longo, Emanuele Ammatuna, Vincenzo Liso, Alberto Bosi, Tiziano Barbui, Alessandro M. Vannucchi

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology

    In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology 由 Tiziano Barbui, Alessandra Carobbio, Elisa Rumi, Guido Finazzi, Heinz Gisslinger, Francesco Rodeghiero, Maria Luigia Randi, Alessandro Rambaldi, Bettina Gisslinger, Lisa Pieri, Irene Bertozzi, Ilaria Carola Casetti, Animesh Pardanani, Francesco Passamonti, Alessandro M. Vannucchi, Ayalew Tefferi

    出版 2014
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  13. 13
    Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts

    Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts 由 Francesco Passamonti, Margherita Maffioli, Francisco Cervantes, Alessandro M. Vannucchi, Enrica Morra, Tiziano Barbui, Domenica Caramazza, Lisa Pieri, Elisa Rumi, Heinz Gisslinger, Laurent Knoops, Jean‐Jacques Kiladjian, Barbara Mora, Norbert Hollaender, Cristiana Pascutto, Claire Harrison, Mario Cazzola

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study

    Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 由 Paola Guglielmelli, Flavia Biamonte, Giada Rotunno, Valentina Artusi, Lucia Artuso, Isabella Bernardis, Elena Tenedini, Lisa Pieri, Chiara Paoli, Carmela Mannarelli, Rajmonda Fjerza, Elisa Rumi, Viktoriya Stalbovskaya, Matthew Squires, Mario Cazzola, Rossella Manfredini, Claire Harrison, Enrico Tagliafico, Alessandro M. Vannucchi

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression

    Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression 由 Thorsten Klampfl, Ashot S. Harutyunyan, Tiina Berg, Bettina Gisslinger, Martin Schalling, Klaudia Bagienski, Damla Olcaydu, Francesco Passamonti, Elisa Rumi, Daniela Pietra, Roland Jäger, Lisa Pieri, Paola Guglielmelli, Ilaria Iacobucci, Giovanni Martinelli, Mario Cazzola, Alessandro M. Vannucchi, Heinz Gisslinger, Róbert Královics

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea

    A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea 由 Srđan Verstovšek, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Peter J. Rosen, Elisa Rumi, Elisabetta Gattoni, Lisa Pieri, Paola Guglielmelli, Chiara Elena, Shui He, Nancy Contel, Bijoyesh Mookerjee, Victor Sandor, Mario Cazzola, Hagop M. Kantarjian, Tiziano Barbui, Alessandro M. Vannucchi

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

    IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis 由 Ayalew Tefferi, Terra L. Lasho, Omar Abdel‐Wahab, Paola Guglielmelli, Jay Patel, Domenica Caramazza, Lisa Pieri, Christy Finke, Outi Kilpivaara, Martha Wadleigh, Ming Mai, Rebecca F. McClure, D. Gary Gilliland, Ross L. Levine, Animesh Pardanani, Alessandro M. Vannucchi

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms

    Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 由 Elena Tenedini, Isabella Bernardis, Valentina Artusi, Lucia Artuso, Enrica Roncaglia, Paola Guglielmelli, Lisa Pieri, Costanza Bogani, Flavia Biamonte, Giada Rotunno, C Mannarelli, Elisa Bianchi, Alessandro Pancrazzi, Tiziana Fanelli, Guidantonio Malagoli Tagliazucchi, Sérgio Ferrari, Rossella Manfredini, Alessandro M. Vannucchi, Enrico Tagliafico

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera

    A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera 由 Federico Lussana, Alessandra Carobbio, Maria Luigia Randi, Chiara Elena, Elisa Rumi, Guido Finazzi, Irene Bertozzi, Lisa Pieri, Marco Ruggeri, Francesca Palandri, Nicola Polverelli, Elena Maria Elli, Alessia Tieghi, Alessandra Iurlo, Marco Ruella, Mario Cazzola, Alessandro Rambaldi, Alessandro M. Vannucchi, Tiziano Barbui

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

    Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis 由 Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy Finke, Emnet A Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Jüergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: